|HQ||South San Francisco, CA, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (3-May-2021)
Closing stock price (3-May-2021)
|USD||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021|
Depreciation and Amortization
Cash From Operating Activities
When was Denali Therapeutics founded?
Denali Therapeutics was founded in 2015.
Who are Denali Therapeutics key executives?
Denali Therapeutics's key executives are Carole Ho, Steve Krognes and Cindy Dunkle.
How many employees does Denali Therapeutics have?
Denali Therapeutics has 261 employees.
What is Denali Therapeutics revenue?
Latest Denali Therapeutics annual revenue is $335.7 m.
What is Denali Therapeutics revenue per employee?
Latest Denali Therapeutics revenue per employee is $1.3 m.
Who are Denali Therapeutics competitors?
Competitors of Denali Therapeutics include Sema4, GenePlanet and Orchard Therapeutics.
Where is Denali Therapeutics headquarters?
Denali Therapeutics headquarters is located at 151 Oyster Point Blvd, South San Francisco.
Where are Denali Therapeutics offices?
Denali Therapeutics has an office in South San Francisco.
How many offices does Denali Therapeutics have?
Denali Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies